NCT02660229

An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.

A 5-day, Multicentre, Randomized, Open-label, Parallel Group, Active Control Pilot Study to Evaluate the Efficacy and Safety of OxyNorm® (Oxycodone Hydrochloride Injection) in Comparison With Morphine Sulfate Through the IV Continuous Infusion Regimen in Patients With Cancer Pain

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Mundipharma Korea Ltd · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare of difference in NRS scores from baseline to the completion of treatment (5 days) in patients with administration of morphine sulfate versus oxycodone hydrochloride.

Detailed description

5days, Multi-centers, Randomization, Open label, Parallel, Active Comparator, Phase 4 Study.

Conditions

• Cancer Pain

Interventions

Type	Name	Description
DRUG	Oxycodone Hydrochloride	Oxycodone injection
DRUG	Morphine Sulphate	Morphine sulphate injection

Timeline

• Start date: 2015-11-01
• Primary completion: 2016-07-01
• Completion: 2016-07-01
• First posted: 2016-01-21
• Last updated: 2018-11-19
• Results posted: 2018-11-19

Locations

1 site across 1 country: South Korea